Drug Target Review – Issue #4 2015

In Issue #4 2015 of Drug Target Review:

• FOREWORD: Avoid falling off a ladder and into the dock
  Jacob Gifford Head, Thomas More Chambers
• BIOMARKERS: Biomarkers as molecular footprints for cancer therapy: current perspectives and promises
  Mahfoozur Rahman and Vikas Kumar, Sam Higginbottom, Institute of Agriculture, Technology & Sciences, Sarwar Beg, Panjab University, and Firoz Anwar, King Abdulaziz University
• IN-DEPTH FOCUS: MASS SPECTROMETRY
  With articles from Michelle M. Hill, University of Queensland, and Nicola Burgess-Brown, Rod Chalk, Claire Strain-Damerell and Pravin Mahajan, Structural Genomics Consortium
• TARGET VALIDATION: The challenges associated with ‘de-risking’ early-stage therapeutic targets
  Ahmad Kamal, Debbie Taylor, Tim Chapman and Catherine Kettleborough, MRC Technology’s Centre for Therapeutics Discovery
• DRUG DEVELOPMENT: Enabling new targets by integrated lead discovery
  Ulrich Schopfer and Sylvain Cottens, Novartis
• PERSONALISED MEDICINES: 3D printing – A new era for personalised medicines?
  Dr Simon Gaisford, University College London School of Pharmacy
• NEXT-GENERATION SEQUENCING: Next-generation transcriptomic analysis in cancer vascular research
  Joseph W. Wragg and Roy Bicknell, University of Birmingham
• PROTEIN EXPRESSION: The growing potential of plant-made monoclonal antibodies
  Qiang “Shawn” Chen and Huafang Lai, Arizona State University
• COMPANION DIAGNOSTICS: Challenges in the development of pharmacist-based point-of-care tests
  Allison M. Dering-Anderson and Meagan Doyle, University of Nebraska College of Pharmacy